AMSBIO has launched GMP grade StemFit® for Differentiation - a chemically defined and animal component-free formulation that enables unmatched differentiation of human Induced Pluripotent Stem (hiPS) and Embryonic Stem (hES) cells. This medium now complies with Good Manufacturing Practices, as required for downstream clinical applications.
The unique chemically defined composition of StemFit® for Differentiation minimizes lot-to-lot variation, enabling highly consistent cell differentiation. The animal-origin free composition minimizes the risk of immunogenic contamination.…
3 July | Babraham Research Campus
Introducing ON Helix 2025ON Helix brings together key players in life sciences to explore critical themes shaping the journey from science to better patient outcomes. Through high quality presentations and panel discussions, ON Helix 2025 will discover and discuss the following themes:• Harnessing the Body’s Defences• Adoption of AI in Innovative Drug Discovery • Getting Ready for Clinic: Transformative Technologies• Invention,…
London, March 13, 2025 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully completed a search assignment for ExpressionEdits and is pleased to announce the placement of Dr. Amrik Basran as Chief Scientific Officer (CSO).ExpressionEdits is a biotechnology company leveraging AI-driven insights and proprietary intronization technology to enhance protein expression.Dr. Basran is a seasoned drug discovery leader with over 20 years of experience, specializing in biologic therapies and antibody mimetics…
Prof Jonathan Jones of The Sainsbury Laboratory at Norwich Research Park awarded Wolf Prize Laureate
Prof Jonathan Jones, of The Sainsbury Laboratory at Norwich Research Park, has been selected as a 2025 Wolf Prize Laureate in Agriculture along with Professors Jeffery L. Dangl and Brian J. Staskawicz "for groundbreaking discoveries of the immune system and disease resistance in plants."
The Wolf Prize is awarded annually to exceptional individuals across scientific and artistic disciplines. In science, the prize is awarded in Medicine, Agriculture, Mathematics, Chemistry, and Physics. Now in its 46th year, the Wolf Prize has recognized 382 scientists and artists worldwide for their…
Arecor Therapeutics plc
(“Arecor” or the “Company”)
ARECOR ESTABLISHES PARTNERSHIP WITH BIOPHARMACEUTICAL COMPANY TO DEVELOP NOVEL FORMULATION OF PEPTIDE THERAPY
- Partner to fund development work with option to acquire rights to proprietary formulation under Arecor’s technology licensing model
Cambridge, UK, 12 March 2025: Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical company advancing today’s therapies to enable healthier lives, today announces a formulation development collaboration with a clinical-stage biopharmaceutical company developing peptide therapies. The partnership…
To mark International Women's Day, the Women in IASP (International Associations of Science Parks) held a global meeting to discuss some of the important issues facing women in science. Women in IASP is a group that was set up to share knowledge and increase the visibility of women in innovation communities worldwide.
Moderated by Roz Bird, CEO of Anglia Innovation Partnership at Norwich Research Park in the UK, the audience heard from Dr. Bindu Nishal from Agri Innovations and One Health at IKP Knowledge Park, India and Prof Keo Shirley Motaung, CEO of Global Health Biotech in South…
Bioscopic, a company that has emerged from research conducted at the Quadram Institute at Norwich Research Park, has been named as one of the #21towatch awards in Cambridge. The awards recognise the people, companies and ‘things’ they create, across Cambridge and the East of England, that are setting the standards in innovation and entrepreneurship across the world.
The annual #21toWatch awards are one of the most recognised entrepreneurship awards in Cambridge and the East of England, featuring in many publications including Forbes and many investor and startup magazines.
Bioscopic is…
Gastronomica, the state-of-the-art food and drink incubator, officially launched at Pioneer Group’s Colworth Science Park on 5 March.
Guests from across the food and drink industry attended the exclusive opening event to view the newly refurbished space as well as demonstrations showcasing the cutting-edge food innovations at Colworth Science Park.
Gastronomica’s official launch was marked by the unveiling of The Herbarium, a herb and seed library that recognises the creators and pioneers who will shape the future of food and drink innovation. Stakeholders involved in curating, investing, and…
Read March eNews here
Featuring:
✅ Why this is a STAR edition, by Tony Jones, CEO, One Nucleus✅ Celebrating Excellence in the One Nucleus Ecosystem, by Tony Jones✅ Winners of the Boston Bootcamp✅ FemTech: The Rapid Growth of Women’s Health Innovation in 2025 by MHA✅ R&D Tax Relief: Introducing the New Merged RDEC and Enhanced R&D Intensive Support Schemes by MHA✅ So You Think You Know One Nucleus? by Tony Jones ✅ The Scientific Sales and Marketing Gap by SAMPS ✅ UK Tax Implications of the Trump Administration by RSM✅ Plus signposts to our Key Events: One Nucleus Awards…
We are delighted to announce the winners of the One Nucleus Boston Bootcamp 2025, a competition aimed at supporting One Nucleus members looking to engage with the Massachusetts Life Science ecosystem.
Following the huge success of its inaugural year in 2024, the Bootcamp established itself as a key initiative for UK Life Science companies looking to expand into the US market - often a crucial step for securing investment, collaborations, or clients. A key factor in its’ success has been the unique structure of the programme, a small, select group of winners travelling together, attending…